OBSOLETE: Other complex syndrome of primary immunodeficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:183716
Who is this for?
Show terms as
10Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

This entry, listed under Orphanet code 183716, refers to a group of complex primary immunodeficiency syndromes that have since been reclassified or merged into more specific disease categories. Primary immunodeficiencies are conditions where the immune system does not work properly from birth, making the body less able to fight infections. People with these conditions often get frequent, severe, or unusual infections that healthy individuals would normally fight off easily. The term 'complex syndrome of primary immunodeficiency' was used as a broad grouping for conditions where immune system problems occurred alongside other features affecting multiple body systems, such as growth problems, skin abnormalities, developmental delays, or organ malformations. Because this classification is now obsolete, patients who were previously grouped under this label have likely been reassigned to more specific diagnoses as medical understanding has improved. If you or a family member was given this diagnosis, it is important to work with a clinical immunologist or geneticist to determine the precise underlying condition. Modern genetic testing can now identify the specific gene changes responsible for many primary immunodeficiencies, which helps guide treatment more effectively. Treatments for primary immunodeficiencies generally include immunoglobulin replacement therapy, preventive antibiotics, and in some cases bone marrow or stem cell transplantation. The exact treatment depends on the specific type of immunodeficiency identified.

Key symptoms:

Frequent or severe infectionsInfections that are hard to treat or keep coming backUnusual infections caused by organisms that rarely affect healthy peoplePoor growth or failure to thrive in childrenSkin rashes or skin problemsDelayed development or intellectual disabilityEnlarged lymph nodes or spleenChronic diarrhea or digestive problemsAutoimmune problems where the body attacks its own tissuesAbnormal facial features or body structure differencesLow blood cell countsChronic lung infections or bronchiectasis

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Oct 2023Immunodeficiency and Cancer: Identification of Congenital Immune System Defects Underlying Paediatric Lymphomas

Meyer Children's Hospital IRCCS — NA

TrialRECRUITING
Sep 2023Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care Unit

University Hospital, Montpellier

TrialRECRUITING
Apr 2023Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults

Qu Biologics Inc. — PHASE2

TrialRECRUITING
Mar 2021Biologics And Clinical Immunology Cohort at Sinai

Icahn School of Medicine at Mount Sinai

TrialRECRUITING
Dec 2020Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency

GC Biopharma Corp — PHASE3

TrialACTIVE NOT RECRUITING
Mar 2020COVID-19 in PID Survey

Imagine Institute

TrialRECRUITING
Feb 2020Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — PHASE2

TrialRECRUITING
Apr 2013Immune Disorder HSCT Protocol

Washington University School of Medicine — PHASE2

TrialACTIVE NOT RECRUITING
Jul 2010Allergy and Immunology Natural History Study

Columbia University

TrialRECRUITING
Feb 2007Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

National Institute of Allergy and Infectious Diseases (NIAID) — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Other complex syndrome of primary immunodeficiency.

10 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

10 recruitingView all trials with filters →
Phase 31 trial
Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
Phase 3
Active
· Sites: Aurora, Colorado; Centennial, Colorado +6 more · Age: 216 yrs
Phase 23 trials
Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults
Phase 2
Actively Recruiting
PI: Theodore Steiner, MD FRCPC (University of British Columbia) · Sites: Burnaby, British Columbia · Age: 6599 yrs
Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
Phase 2
Actively Recruiting
PI: Heather J Symons, MD, MHS (Johns Hopkins University) · Sites: Baltimore, Maryland · Age: 450 yrs
Immune Disorder HSCT Protocol
Phase 2
Active
· Sites: St Louis, Missouri · Age: 021 yrs
N/A2 trials
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
N/A
Actively Recruiting
PI: Helen C Su, M.D. (National Institute of Allergy and Infectious Disea) · Sites: Bethesda, Maryland; Ann Arbor, Michigan +5 more · Age: 1100 yrs
Immunodeficiency and Cancer: Identification of Congenital Immune System Defects Underlying Paediatric Lymphomas
N/A
Actively Recruiting
PI: Eleonora Gambineri (Meyer Children's Hospital IRCCS) · Sites: Bologna; Florence +2 more · Age: 124 yrs
Other4 trials
Allergy and Immunology Natural History Study
Actively Recruiting
PI: Joshua D. Milner, MD (Columbia University) · Sites: New York, New York · Age: 099 yrs
Biologics And Clinical Immunology Cohort at Sinai
Actively Recruiting
PI: Rachel Miller (Icahn School of Medicine) · Sites: New York, New York · Age: 1299 yrs
COVID-19 in PID Survey
Actively Recruiting
PI: Nizar MAHLAOUI, MD, MPH, PhD (Necker Enfants Malades University Hospital) · Sites: Paris
Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care Unit
Actively Recruiting
PI: Eric JEZIORSKI (University Hospital, Montpellier) · Sites: Montpellier · Age: 016 yrs

No specialists are currently listed for OBSOLETE: Other complex syndrome of primary immunodeficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Other complex syndrome of primary immunodeficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Other complex syndrome of primary immunodeficiencyForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Other complex syndrome of primary immunodeficiency.

Start the conversation →

Latest news about OBSOLETE: Other complex syndrome of primary immunodeficiency

No recent news articles for OBSOLETE: Other complex syndrome of primary immunodeficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Can you identify the specific type of primary immunodeficiency I or my child has?,What genetic testing should be done to get a more precise diagnosis?,Will immunoglobulin replacement therapy be needed, and if so, how often?,Are there any vaccines that should be avoided?,What signs of infection should prompt an emergency room visit?,Is bone marrow transplantation or gene therapy an option for this condition?,Should other family members be tested for this condition?

Common questions about OBSOLETE: Other complex syndrome of primary immunodeficiency

What is OBSOLETE: Other complex syndrome of primary immunodeficiency?

This entry, listed under Orphanet code 183716, refers to a group of complex primary immunodeficiency syndromes that have since been reclassified or merged into more specific disease categories. Primary immunodeficiencies are conditions where the immune system does not work properly from birth, making the body less able to fight infections. People with these conditions often get frequent, severe, or unusual infections that healthy individuals would normally fight off easily. The term 'complex syndrome of primary immunodeficiency' was used as a broad grouping for conditions where immune system p

Are there clinical trials for OBSOLETE: Other complex syndrome of primary immunodeficiency?

Yes — 10 recruiting clinical trials are currently listed for OBSOLETE: Other complex syndrome of primary immunodeficiency on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.